References
- KantersSVitoriaMDohertyMComparative efficacy and safety of first-line antiretroviral therapy for the treatment of HIV infection: a systematic review and network meta-analysisLancet HIV2016311e510e52027658869
- TrottierBMachoufNHuchetETolerability is more important than simplicity for treatment durabilityJ Int AIDS Soc2014174 Suppl 31976525397509
- MillerLGHuffmanHBWeidmerBAHaysRDPatient preferences regarding antiretroviral therapyInt J STD AIDS200213959360112230922
- ShererRDJrFathMJDa SilvaBANicolauAMMillerNLThe importance of potency and durability in HIV patient antiretroviral therapy preferences: a telephone surveyAIDS patient Care STDs2005191279480216375611
- EatonEFTamhaneABurkholderGWilligJSaagMMugaveroMJUnanticipated effects of new drug availability on antiretroviral durability: implications for comparative effectiveness researchOpen Forum Infect Dis201632ofw10927419181
- McKinnellJAWilligJHWestfallAOAntiretroviral prescribing patterns in treatment-naive patients in the United StatesAIDS patient Care STDs2010242798520059309
- MuhlbacherACStollMMahlichJNublingMPatient preferences for HIV/AIDS therapy – a discrete choice experimentHealth Econ Rev2013311423663390
- GazzardBAliSMuhlbacherAPatient preferences for characteristics of antiretroviral therapies: results from five European countriesJ Int AIDS Soc2014174 Suppl 31954025394048
- The Centers for Disease ControlHIV in the United States: At A Glance Available from http://www.cdc.gov/hiv/pdf/statistics_basics_ata-glance_factsheet.pdfAccessed February 26, 2016
- WalkerJLThe use of saturation in qualitative researchCan J Cardiovasc Nurs2012222374622803288
- HarveyNHolmesCANominal group technique: an effective method for obtaining group consensusInt J Nurs Pract201218218819422435983
- LucasAGPrimusKKovachJVFredendallLDRethinking behavioral health processes by using design for six sigmaPsychiatr Serv201566211211425642607
- MugaveroMJAmicoKRHornTThompsonMAThe state of engagement in HIV care in the United States: from cascade to continuum to controlClin Infect Dis20135781164117123797289
- Centers for Disease Control and PreventionLifetime Risk of HIV Diagnosis Available from http://www.cdc.gov/nchhstp/newsroom/2016/croi-press-release-risk.htmlAccessed March 7, 2016
- DeeksSGPhillipsANHIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidityBMJ2009338a317219171560
- DuncanCJSchmidMLSchwabUPriceDAOngEFutility of CD4+ monitoring in HIV-1 patients with CD4+ cell count above 350 cells/mul on suppressive antiretroviral therapyAIDS (London, England)2014281726382639